Results 211 to 220 of about 79,325 (265)
Some of the next articles are maybe not open access.
Annals of Internal Medicine, 1987
Excerpt To the editor: Graves disease with ophthalmopathy was diagnosed in a 37-year-old woman. Treatment consisted of propranolol, 20 mg three times a day, propylthiouracil, 100 mg three times a d...
Noppen, Marc +4 more
openaire +2 more sources
Excerpt To the editor: Graves disease with ophthalmopathy was diagnosed in a 37-year-old woman. Treatment consisted of propranolol, 20 mg three times a day, propylthiouracil, 100 mg three times a d...
Noppen, Marc +4 more
openaire +2 more sources
Folia Microbiologica, 1995
This review presents the progress and some aspects achieved during recent years with cyclosporin sources, chemistry, biological activities, side effects, biosynthesis and metabolism. Although incomplete the results indicate future research trends and some white spots to be studied in the near future to afford unique insights into cell biology and to ...
openaire +2 more sources
This review presents the progress and some aspects achieved during recent years with cyclosporin sources, chemistry, biological activities, side effects, biosynthesis and metabolism. Although incomplete the results indicate future research trends and some white spots to be studied in the near future to afford unique insights into cell biology and to ...
openaire +2 more sources
Clinics in Dermatology, 1991
Abstract Cyclosporine A (CyA) is a potent immunosuppressive agent with a selective and reversible inhibitory effect on T-cell functions, especially interleukin-2 production. The drug is not myelotoxic, mutagenic, or teratogenic and is extremely effective in preventing rejection of grafted organs.
openaire +2 more sources
Abstract Cyclosporine A (CyA) is a potent immunosuppressive agent with a selective and reversible inhibitory effect on T-cell functions, especially interleukin-2 production. The drug is not myelotoxic, mutagenic, or teratogenic and is extremely effective in preventing rejection of grafted organs.
openaire +2 more sources
Cyclosporine and Prostaglandins
Annals of Internal Medicine, 1985Excerpt To the editor: Cyclosporine and its nephrotoxicity have recently been reviewed in your journal (1). Subsequently, Dr.
D, Adu +4 more
openaire +2 more sources
Clinical Infectious Diseases, 1989
Cyclosporine is a potent immunosuppressive agent that selectively impairs T cell function. The steady growth of its importance makes knowledge of its activity and effects clinically relevant. The intrinsic antibiotic activity of cyclosporine is limited; although it inhibits certain viruses, fungi, protozoa, and helminths, in practical terms these ...
J H, Kim, J R, Perfect
openaire +2 more sources
Cyclosporine is a potent immunosuppressive agent that selectively impairs T cell function. The steady growth of its importance makes knowledge of its activity and effects clinically relevant. The intrinsic antibiotic activity of cyclosporine is limited; although it inhibits certain viruses, fungi, protozoa, and helminths, in practical terms these ...
J H, Kim, J R, Perfect
openaire +2 more sources
Revue de Stomatologie et de Chirurgie Maxillo-faciale, 2005
info:eu-repo/semantics ...
Loeb, Isabelle, Hermans, Paul
openaire +2 more sources
info:eu-repo/semantics ...
Loeb, Isabelle, Hermans, Paul
openaire +2 more sources
Experientia, 1992
The systemic effect of the immunosuppressive drug cyclosporine (CS) on formation of new blood vessels was studied quantitatively in rats using the mesenteric-window assay. Angiogenesis was induced by i.p. injection of saline. CS at a s.c. dose of 4 mg/kg/day, which is in the range used clinically, suppressed angiogenesis (inhibiting branching or ...
openaire +2 more sources
The systemic effect of the immunosuppressive drug cyclosporine (CS) on formation of new blood vessels was studied quantitatively in rats using the mesenteric-window assay. Angiogenesis was induced by i.p. injection of saline. CS at a s.c. dose of 4 mg/kg/day, which is in the range used clinically, suppressed angiogenesis (inhibiting branching or ...
openaire +2 more sources
Cyclosporine A: Chemistry and Toxicity – A Review
Current Medicinal Chemistry, 2021Kamil Kuca +2 more
exaly

